首页> 美国卫生研究院文献>Cancer Medicine >The clinicopathological significance of NAB2‐STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors
【2h】

The clinicopathological significance of NAB2‐STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors

机译:NAB2-STAT6基因融合在52例胸腔孤立性纤维瘤中的临床病理意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

NAB2‐STAT6 gene fusion drives STAT6 nuclear expression and is the pathognomonic hallmark of solitary fibrous tumors (SFTs). However, no study has systematically analyzed the clinicopathological features, STAT6 immunoexpression status, or the fusion variants of NAB2‐STAT6 in intrathoracic SFTs. Fifty‐two intrathoracic SFTs were retrieved to appraise histopathology, assess STAT6 immunoexpression, and determine NAB2‐STAT6 fusion variants by RT‐PCR. Location‐relevant histologic mimics served as controls. Thirty‐one pleura‐based, 12 mediastinal/pericardial, and nine intrapulmonary lesions were histologically categorized into eight malignant, eight atypical, and 36 conventional or cellular SFTs, including two fat‐forming and two giant cell angiofibroma‐like SFTs. style="fixed-case">STAT6 distinctively decorated the tumoral nuclei in 51 (98%) style="fixed-case">SFTs. However, no nuclear staining was observed in the histological mimics. style="fixed-case">NAB2‐ style="fixed-case">STAT6 fusion was detected in 34 style="fixed-case">SFTs. Twenty‐nine (85.3%) exhibited the major style="fixed-case">NAB2ex4‐ style="fixed-case">STAT6ex2/3 variant and 5 (14.7%) the minor style="fixed-case">NAB2ex6‐ style="fixed-case">STAT6ex16/17. style="fixed-case">NAB2ex4‐ style="fixed-case">STAT6ex2 was significantly associated with older age (P = 0.01) and pleuropulmonary tumors (P = 0.025). After a median follow‐up of 33.9 (range, 0.3–174.6) months, adverse outcomes occurred in one atypical and five malignant style="fixed-case">SFTs, including two local relapses, one intrapulmonary metastasis, and three extrathoracic metastases. Inferior disease‐free survival was univariately associated with atypical/malignant histology (P = 0.001) and a mitosis >4/10 style="fixed-case">HPFs (P = 0.0012) but was unrelated to fusion variants. In conclusion, the majority of intrathoracic style="fixed-case">SFTs exhibited style="fixed-case">STAT6 nuclear staining, and style="fixed-case">NAB2ex4‐ style="fixed-case">STAT6ex2/3 was the predominant fusion type. However, clinical aggressiveness is associated with atypical/malignant histology primarily contributed by increased mitosis but was unrelated to the style="fixed-case">NAB2‐ style="fixed-case">STAT6 fusion variants.
机译:NAB2-STAT6基因融合驱动STAT6核表达,是孤立性纤维性肿瘤(SFT)的病理标志。但是,尚无研究系统地分析胸腔内SFT中的临床病理特征,STAT6免疫表达状态或NAB2-STAT6的融合变体。取回52个胸腔内SFT,以评估组织病理学,评估STAT6免疫表达并通过RT-PCR确定NAB2-STAT6融合变体。与位置相关的组织学模拟物作为对照。在组织学上将基于胸膜的31例,纵隔/心包的12例和肺内9例病变分为8例恶性,8例非典型和36例常规或细胞SFT,包括2例脂肪形成和2例巨细胞血管纤维瘤样SFT。 style =“ fixed-case”> STAT 6在51(98%) style =“ fixed-case”> SFT s中显着修饰了肿瘤核。但是,在组织学模拟物中未观察到核染色。在34个 style =“ fixed-case”> SFT <中检测到 style =“ fixed-case”> NAB 2- style =“ fixed-case”> STAT 6融合/ span> s。 29(85.3%)展示了主要的 style =“ fixed-case”> NAB 2ex4‐ style =“ fixed-case”> STAT 6ex2 / 3和5(14.7 %)次要 style =“ fixed-case”> NAB 2ex6‐ style =“ fixed-case”> STAT 6ex16 / 17。 style =“ fixed-case”> NAB 2ex4- style =“ fixed-case”> STAT 6ex2与年龄较大(P = 0.01)和胸膜肺肿瘤(P = 0.025)。在中位随访33.9(范围0.3-174.6)个月后,不良反应发生在一个非典型的和五个恶性的 style =“ fixed-case”> SFT 中,包括两个局部复发,一个肺内转移和三个胸外转移。无病生存期与非典型/恶性组织学(P = 0.001)和有丝分裂> 4/10 style =“ fixed-case”> HPF s(P = 0.0012)单相关,但与融合变体。总之,大多数胸腔内 style =“ fixed-case”> SFT 表现出 style =“ fixed-case”> STAT 6核染色,而 style =“ fixed -case“> NAB 2ex4- style =” fixed-case“> STAT 6ex2 / 3是主要的融合类型。但是,临床侵略性与主要由有丝分裂增加引起的非典型/恶性组织学有关,但与 style =“ fixed-case”> NAB 2- style =“ fixed-case”> STAT < / span> 6个融合变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号